Free Trial
→ Here’s How to Claim Your Stake in Elon’s Private Company, xAI (From Brownstone Research) (Ad) Buy VRPX Stock  Free VRPX Stock Alerts

Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume

Virpax Pharmaceuticals logo
$0.26 +0.05 (+23.81%)
As of 11:27 AM Eastern
Compare

Virpax Pharmaceuticals Short Interest Data

Virpax Pharmaceuticals (VRPX) has a short interest of 319,800 shares, representing 26.21% of the float (the number of shares available for trading by the public). This marks a 1,284.42% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 199,939 shares to cover all short positions.

Current Short Interest
319,800 shares
Previous Short Interest
23,100 shares
Change Vs. Previous Month
+1,284.42%
Dollar Volume Sold Short
$383,760.00
Short Interest Ratio
0.8 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
1,242,000 shares
Float Size
1,220,000 shares
Short Percent of Float
26.21%
Today's Trading Volume
16,277 shares
Average Trading Volume
199,939 shares
Today's Volume Vs. Average
8%
Short Selling Virpax Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VRPX Short Interest Over Time

VRPX Days to Cover Over Time

VRPX Percentage of Float Shorted Over Time

Remove Ads

Virpax Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2025319,800 shares $383,760.00 +1,284.4%26.2%0.8 $1.20
3/15/202523,100 shares $96,153.75 -97.6%1.9%0.1 $4.16
2/28/2025955,300 shares $229,272.00 -39.2%3.7%0.2 $0.24
2/15/20251,570,000 shares $512,291.00 +148.7%8.7%0.2 $0.33
1/31/2025631,300 shares $197,028.73 +437.3%3.6%0.2 $0.31
1/15/2025117,500 shares $41,125.00 -74.3%0.8%0 $0.35
12/31/2024457,500 shares $173,804.25 +90.3%3.2%0.1 $0.38
12/15/2024240,400 shares $96,160.00 -37.8%3.1%0.1 $0.40
11/30/2024386,500 shares $178,176.50 +22.7%5.1%0.1 $0.46
11/15/2024315,000 shares $193,473.00 -10.2%4.2%0.1 $0.61
10/31/2024350,900 shares $257,209.70 -38.0%7.6%1.2 $0.73
10/15/2024565,500 shares $249,951.00 +46.7%12.3%1.5 $0.44
9/30/2024385,600 shares $267,760.64 -7.2%8.4%0.1 $0.69
9/15/2024415,300 shares $344,034.52 -20.6%9.1%0.1 $0.83
8/31/2024523,200 shares $426,512.64 +241.1%11.4%0.1 $0.82
8/15/2024153,400 shares $130,236.60 -42.9%3.3%0 $0.85
7/31/2024268,400 shares $327,448.00 -57.5%6.2%0 $1.22
7/15/2024631,600 shares $675,812.00 +1,625.7%14.8%0.1 $1.07
6/30/202436,600 shares $18,933.18 +28.4%1.5%0 $0.52
6/15/202428,500 shares $19,531.05 -49.7%1.2%0.2 $0.69
5/31/202456,700 shares $39,690.00 -28.8%2.8%0.6 $0.70
5/15/202479,600 shares $62,088.00 +907.6%5.1%0.9 $0.78
4/30/20247,900 shares $21,409.00 -46.6%0.9%0.3 $2.71
4/15/202414,800 shares $52,248.44 -50.3%1.7%0.6 $3.53
3/31/202429,800 shares $126,983.76 +24.7%3.4%1.3 $4.26
3/15/202423,900 shares $99,663.00 +119.3%2.8%1 $4.17
2/29/202410,900 shares $33,266.80 -82.5%1.3%0.3 $3.05
2/15/202462,400 shares $22,938.24 -12.2%0.7%0.2 $0.37
1/31/202471,100 shares $23,391.90 +38.1%0.8%0.2 $0.33
1/15/202451,500 shares $13,750.50 -44.1%0.6%0.2 $0.27
12/31/202392,100 shares $29,481.30 +479.3%1.1%0.3 $0.32
12/15/202315,900 shares $6,224.85 -58.4%0.2%0.1 $0.39
11/30/202338,200 shares $15,272.36 -30.3%0.4%0.7 $0.40
11/15/202354,800 shares $40,661.60 -8.8%0.6%2.1 $0.74
10/31/202360,100 shares $42,983.52 +110.1%0.7%2.4 $0.72
10/15/202328,600 shares $23,457.72 -40.3%0.3%1.1 $0.82
9/30/202347,900 shares $38,315.21 +197.5%0.6%2.3 $0.80
9/15/202316,100 shares $12,702.90 -37.6%0.2%0.7 $0.79
8/31/202325,800 shares $22,188.00 -22.8%0.3%0.8 $0.86
8/15/202333,400 shares $29,893.00 -20.1%0.4%1 $0.90
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
7/31/202341,800 shares $37,202.00 +1.7%0.5%1.3 $0.89
7/15/202341,100 shares $40,278.00 -48.1%0.5%1.3 $0.98
6/30/202379,200 shares $85,536.00 +56.8%0.9%2.6 $1.08
6/15/202350,500 shares $46,460.00 -35.2%0.6%1.8 $0.92
5/31/202377,900 shares $61,143.71 -26.1%0.9%4.2 $0.78
5/15/2023105,400 shares $90,654.54 +22.3%1.2%6.1 $0.86
4/30/202386,200 shares $61,245.10 +2.9%1.0%4.1 $0.71
4/15/202383,800 shares $64,291.36 -7.7%1.0%2.1 $0.77
3/31/202390,800 shares $71,278.00 +7.3%1.0%2.3 $0.79
3/15/202384,600 shares $67,680.00 +6.8%1.0%1.8 $0.80
2/28/202379,200 shares $74,677.68 -40.4%0.9%1.6 $0.94
2/15/2023132,900 shares $145,339.44 +285.2%1.6%2.6 $1.09
1/31/202334,500 shares $34,148.10 +1.8%0.4%0.7 $0.99
1/15/202333,900 shares $28,137.00 -18.9%0.4%0.9 $0.83
12/30/202241,800 shares $26,012.14 -51.1%0.5%1 $0.62
12/15/202285,400 shares $68,320.00 +100.9%1.0%2.3 $0.80
11/30/202242,500 shares $35,700.00 +21.1%0.5%1.2 $0.84
11/15/202235,100 shares $30,105.27 +19.0%0.4%1 $0.86
10/31/202229,500 shares $31,565.00 +16.6%0.3%0.7 $1.07
10/15/202225,300 shares $27,071.00 -39.3%0.3%0.5 $1.07
9/30/202241,700 shares $49,623.00 +37.6%0.5%0.9 $1.19
9/15/202230,300 shares $39,693.00 +5.6%0.4%0.6 $1.31
8/31/202228,700 shares $36,449.00 -22.9%0.3%0.5 $1.27
8/15/202237,200 shares $62,496.00 -45.7%0.4%0.6 $1.68
7/31/202268,500 shares $104,120.00 +78.9%0.8%0.8 $1.52
7/15/202238,300 shares $62,046.00 -41.1%0.5%0.3 $1.62
6/30/202265,000 shares $109,200.00 -15.1%0.8%0.4 $1.68
6/15/202276,600 shares $107,240.00 -12.6%0.9%0.5 $1.40
5/31/202287,600 shares $124,392.00 -35.0%1.0%0.5 $1.42
5/15/2022134,800 shares $180,632.00 +61.8%1.5%0.8 $1.34
4/30/202283,300 shares $147,441.00 +1.0%1.0%0.5 $1.77
4/15/202282,500 shares $165,825.00 +32.4%0.9%0.6 $2.01
3/31/202262,300 shares $138,306.00 +3.2%0.7%0.4 $2.22
3/15/202260,400 shares $121,404.00 -4.9%0.7%0.3 $2.01
2/28/202263,500 shares $137,795.00 +15.9%0.7%0.1 $2.17
2/15/202254,800 shares $126,588.00 -22.6%0.6%0.1 $2.31
1/31/202270,800 shares $150,804.00 +17.8%0.8%0.1 $2.13
1/15/202260,100 shares $172,487.00 -70.4%0.7%0.1 $2.87
12/31/2021203,000 shares $696,290.00 -30.7%N/A0.2 $3.43
12/15/2021293,000 shares $1.13 million +222.0%3.3%0.3 $3.85
11/30/202191,000 shares $425,880.00 -60.5%1.0%0.1 $4.68
11/15/2021230,100 shares $991,731.00 -3.6%2.6%0.2 $4.31
10/29/2021238,800 shares $998,184.00 +8.2%2.7%0.1 $4.18
10/15/2021220,700 shares $988,736.00 -25.2%2.5%0 $4.48
9/30/2021294,900 shares $1.42 million -11.1%3.3%0.1 $4.80
9/15/2021331,600 shares $2.00 million +35.2%6.8%0.1 $6.02
8/31/2021245,200 shares $4.68 million +103.8%11.9%0 $19.10
8/13/2021120,300 shares $544,959.00 No Change5.8%0 $4.53

VRPX Short Interest - Frequently Asked Questions

What is Virpax Pharmaceuticals' current short interest?

Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 319,800 shares of VRPX short. 26.21% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest.

What is a good short interest ratio for Virpax Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRPX shares currently have a short interest ratio of 1.0. Learn More on Virpax Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Virpax Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.21% of Virpax Pharmaceuticals' floating shares are currently sold short.

Is Virpax Pharmaceuticals' short interest increasing or decreasing?

Virpax Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 319,800 shares, an increase of 1,284.4% from the previous total of 23,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Virpax Pharmaceuticals' float size?

Virpax Pharmaceuticals currently has issued a total of 1,242,000 shares. Some of Virpax Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virpax Pharmaceuticals currently has a public float of 1,220,000 shares.

How does Virpax Pharmaceuticals' short interest compare to its competitors?

26.21% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virpax Pharmaceuticals: Eterna Therapeutics Inc. (1.12%), Viracta Therapeutics, Inc. (0.66%), Windtree Therapeutics, Inc. (37.32%), Galmed Pharmaceuticals Ltd. (3.07%), Enveric Biosciences, Inc. (7.74%), Syros Pharmaceuticals, Inc. (17.70%), GRI Bio, Inc. (9.06%), Petros Pharmaceuticals, Inc. (14.90%), Biora Therapeutics, Inc. (6.64%), Avenue Therapeutics, Inc. (2.95%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Virpax Pharmaceuticals stock?

Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. VRPX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Virpax Pharmaceuticals?

A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further.

How often is Virpax Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is March, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:VRPX) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Feds Just Admitted It—They Can Take Your Cash
Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...
Priority Gold | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored